Da vildagliptin har været forbundet med leverproblemer, skal patienterne have foretaget tests for at kontrollere deres lever, før behandling med Xiliarx påbegyndes og med jævne mellemrum under behandlingen.
Because vildagliptin has been associated with liver problems, patients should have tests to check their liver before treatment with Xiliarx and at regular intervals during treatment.